First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Nov 16
 +1.58 / +1.18%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month-6.30% 3 years+7.60%
3 months-9.51% 5 years+15.24%
1 year+11.47% Since inception+16.69%
Data through 11/16/2018

Quote Details

Previous close$133.88
Open day’s range132.88 – 136.36
Net asset value (NAV)133.95 (11/15/2018)
Daily volume111,808
Average volume (3 months)317,766
Data as of 3:59pm ET, 11/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+15.24%+14.62%
Expense Gross exp ratio0.56%1.28%
Risk 5 year sharpe ratio0.700.77
Net assets$2.7B$3.2B
Average market cap$11.2B$27.2B
Average P/E21.927.5
Dividend / Share--0.31%


FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc3.93%
GRFS Grifols SA3.78%
ALNY Alnylam Pharmaceuticals Inc3.76%
ALKS Alkermes Plc3.64%
QGEN Qiagen NV3.62%
ICPT Intercept Pharmaceuticals Inc3.59%
CRL Charles River Laboratories International Inc3.57%
ILMN Illumina Inc3.56%
INCY Incyte Corp3.51%
IQV Iqvia Holdings Inc3.47%